Zana Technologies is a deep tech healthcare company based in Germany, founded in 2018. The company leverages advanced AI and voice technology to support better health outcomes. Their AI-driven solutions focus on extracting digital voice biomarkers — quantifiable features from voice samples that offer insights into physical and mental well-being. Zana is particularly focused on respiratory diseases and cardiology, aiming to digitize clinical trials, enhance remote monitoring, and enable earlier detection of health issues to improve patient care and reduce healthcare costs.

Zana's mission centers on the ethical use of AI and data to make healthcare more human through conversational and voice-AI technologies. They have developed a scalable platform that continuously collects and analyzes voice data, providing predictive health scores integrated into healthcare systems. Their efforts include pioneering clinical studies, such as the UNISONO Acute Heart Failure Voice Study, and partnerships with leading medical institutions and industry partners to drive innovation and practical deployment of voice biomarkers in healthcare.